Effect of Saxagliptin and Dapagliflozin on Endothelial Progenitor Cell in Patients With Type 2 Diabetes Mellitus

NCT03660683 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Sponsor did not want to continue funding the study

Conditions

Diabetes Mellitus, Type 2
Cardiovascular Diseases

Interventions

DRUG: Dapagliflozin 10mg
DRUG: Saxagliptin 5mg
DRUG: Placebo Oral Tablet

Sponsor

Sabyasachi Sen